Passage Bio
-$0.01 (-0.40%) As of 2:15 PM UTC today
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Passage Bio and other ETFs, options, and stocks.
About PASG
Passage Bio, Inc. operates as a genetic medicines company. It focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options.
CEO
Edgar B. Cale
Employees
133
Headquarters
Philadelphia, Pennsylvania
Founded
2017
PASG Key Statistics
Market cap
133.60M
Price-Earnings ratio
—
Dividend yield
—
Average volume
709.62K
High today
$2.53
Low today
$2.40
Open price
$2.50
Volume
43.60K
52 Week high
$14.10
52 Week low
$1.57
Analyst ratings
75%
of 8 ratings
Buy
75%
Hold
25%
Sell
0%
PASG Earnings
-$0.95
-$0.63
-$0.32
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, Pre-Market